Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL99832 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL100741 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL101628 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL101603 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL102969 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL23577086 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL101803 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL201904 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL200853 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL102911 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4382546-A1 | POLY(UREA-URETHANE) POLYMER | BASF SE (DE) | 2024-06-12 | — | — | EP | disclosed |
| WO-2024105029-A1 | RECYCLABLE POLY(UREA-URETHANE) POLYMER AND COMPOSITE WITH DYNAMIC HINDERED UREA BONDS (HUBS) | BASF SE (DE) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024105027-A1 | CLOSED LOOP RECYCLING CONCEPT FOR COMPOSITES COMPRISING COVALENT ADAPTABLE POLY(UREA-URETHANE) NETWORKS WITH DYNAMIC HINDERED UREA BONDS | BASF SE (DE) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024061814-A1 | CONDITIONER WITH IMPROVED MANAGEABILITY | WELLA GERMANY GMBH (DE) | 2024-03-28 | — | — | WO | disclosed |
| EP-4342444-A1 | CONDITIONER WITH IMPROVED MANAGEABILITY | Wella Germany GmbH (DE) | 2024-03-27 | — | — | EP | disclosed |
| EP-4305085-A1 | POLYUREA COPOLYMER | BASF SE (DE) | 2024-01-17 | — | — | EP | disclosed |
| CN-117242116-A | Triazinyl ultraviolet absorbing polymers | 巴斯夫欧洲公司 | 2023-12-15 | — | — | CN | disclosed |
| WO-2023213785-A1 | UV LIGHT STABILIZERS | BASF SE (DE) | 2023-11-09 | — | — | WO | disclosed |
| CN-116964122-A | Polyurea copolymers | 巴斯夫欧洲公司 | 2023-10-27 | — | — | CN | disclosed |
| WO-2023161023-A1 | ULTRAVIOLET ABSORBER | BASF SE (DE) | 2023-08-31 | — | — | WO | disclosed |
| WO-2010111822-A1 | OLIGOCONDENSED PERYLENE BISIMIDES | BASF SE (DE) | 2010-10-07 | — | — | WO | disclosed |
| US-20100048904-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-25 | — | — | US | disclosed |
| EP-2029573-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2009-03-04 | — | — | EP | disclosed |
| EP-2008319-A2 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007138051-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007116001-A2 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2007-10-18 | — | — | WO | disclosed |
| EP-1843407-A1 | Liquid crystalline rylenetetracarboxylic acid derivatives and their use | BASF AKTIENGESELLSCHAFT (DE) | 2007-10-10 | — | — | EP | disclosed |
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048904-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | TDO2, C9, CYP3A43 | LMNA 1646/4885ALDH1A1 627/4885TDP1 3791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.